October 23, 2014

The U.S. healthcare system must address the problem of patients not picking up newly-prescribed medicines, according to a NEHI white paper.

October 22, 2014

Amneal Pharmaceuticals on Tuesday announced that the company has won the global “Company of the Year” Award from Generics bulletin.

October 22, 2014

The Food and Drug Administration last week announced plans to survey pharmacists and patients about their experiences resulting from changes in generic drug pill appearance.

October 22, 2014

Adult millennials ages 18 years to 32 years worry about their health and access to health care as much as their baby boomer elders.

October 21, 2014

H.D. Smith on Monday appointed Rob Meriweather as VP sales.

 

October 21, 2014

McKesson and Health Mart on Monday featured solutions designed to help community pharmacies deliver better patient care and sustain growth.

 

October 21, 2014

A team of scientists, led by researchers at the Wistar Institute, has identified a possible explanation for why middle-aged adults were hit especially hard by the H1N1 influenza virus during the 2013-14 influenza season.

 

October 20, 2014

Cardinal Health on Monday announced that independent pharmacies can now take advantage of opportunities to co-brand with the Medicine Shoppe and Medicap Pharmacy franchising systems.

October 20, 2014

CVS Health has confirmed a Wall Street Journal report that it is working to establish a tobacco-free pharmacy network and is looking for tobacco-free pharmacies to participate in the new offering.

October 17, 2014

A new study published Thursday by the Center for Healthcare Supply Chain Research identifies factors, based on an analysis of European models, that may affect the American launch of biosimilars and their marketplace potential in the United States.

October 17, 2014

Healthentic, an analytics company that identifies health savings for employers, found the overall vaccination rate of employees was only 10%.

October 15, 2014

 H. D. Smith was recently announced as a finalist of the 2014 Illinois Family Business of the Year Awards in the Large Family Business of the Year and the Community Service categories.

October 15, 2014

Could the regulatory and scientific logjam that’s keeping copycat biotech medicines off the market and out of the hands of patients and health providers in the United States finally be breaking?

October 15, 2014

The U.S. Supreme Court on Wednesday heard arguments from Teva Pharmaceutical Industries in defense of the patent protecting its $4 billion multiple sclerosis drug Copaxone, according to a Reuters report. 

October 15, 2014

As the Food and Drug Administration begins to explore ways to improve its user-fee program for generic drugs, the Generic Pharmaceutical Association and its members have weighed in with suggestions on how to shore up the law to ensure that it helps bring generics to market faster and provides benefits across the entire healthcare system.

October 15, 2014

What’s in a name? A lot, apparently, if the name applies to a biosimilar medicine.

October 14, 2014

U.S. Sen. Bernie Sanders, I-Vt., and U.S. Rep. Elijah Cummings, D-Md., earlier this month launched an investigation into soaring generic drug prices.

October 14, 2014

Healthgrades on Monday announced the launch of its new Cold and Flu Center at http://www.healthgrades.com/right-care/cold-and-flu/.

October 14, 2014

Impax Labs last week announced the execution of a definitive agreement under which Impax will acquire Tower Holdings. 

October 14, 2014

Twenty African-American and Hispanic community and health care organizations earlier this month submitted a letter to the Food and Drug Administration raising concerns that its Proposed Rule on Generic Labeling could jeopardize patient safety and access to affordable medicines. 

October 14, 2014

The Pharmaceutical Research and Manufacturers of America on Tuesday launched AccessBetterCoverage.org.

 

October 10, 2014

The Drug Enforcement Administration’s final rule moving hydrocodone combination products from Schedule III to the more-restrictive Schedule II officially went into effect on Monday. 

October 9, 2014

The Food and Drug Administration earlier this month issued draft guidance with several recommendations for manufacturers of acetaminophen products. 

October 8, 2014

"What happens when student pharmacists discover that their professional path may prove equal parts public health and public policy?"